Atlas Trials

A Study of the Immunogenicity and Safety of Whole-Cell Pertussis Containing Vaccine Administered Concomitantly With RotaTeq™ (V260) or Rotarix™ (V260-036)(WITHDRAWN)

Clinical trial NCT01003431 · WITHDRAWN

Trial details

NCT number
NCT01003431
Sponsor
Merck Sharp & Dohme LLC
Status
WITHDRAWN
Phase
Phase 3
Study type
INTERVENTIONAL
Rotavirus GastroenteritisDiphtheriaTetanusPertussis
Start date
2009-12-01
Primary completion
2010-08-01
Enrollment
0

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.